Purple Biotech Income Statement (2014-2026) | PPBT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Depreciation & Amortization - Total (Quarter)	0.06M	0.06M	0.06M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.04M	0.04M	0.05M	0.06M	0.05M	0.07M
Research & Development (Quarter)	2.09M	1.62M	3.25M	5.95M	2.08M	3.46M	4.82M	3.50M	3.71M	4.59M	5.24M	3.42M	2.39M	1.35M	0.46M	0.76M	0.55M	0.59M	1.83M	1.23M
Share-based Compensation (IS) (Quarter)	0.68M	0.39M	0.30M	0.31M	0.56M	0.71M	0.84M	0.75M	0.49M	0.45M	0.18M	0.27M	0.22M	0.13M	-0.34M	0.09M	0.06M	0.20M	-0.24M	0.09M
Selling, General & Administrative (Quarter)	1.53M	1.42M	1.49M	1.38M	1.51M	1.62M	1.78M	1.62M	1.43M	1.16M	1.02M	1.04M	0.86M	0.79M	0.56M	0.65M	0.68M	0.78M	1.14M	1.02M
Other Operating Expenses (Quarter)	-0.06M	0.09M	2.98M		-0.05M
Operating Expenses (Quarter)	3.62M	3.20M	7.78M	7.38M	3.59M	5.13M	6.65M	5.17M	5.19M	5.80M	6.32M	4.51M	3.31M	2.18M	1.06M	1.45M	1.28M	1.43M	3.02M	2.32M
Operating Income (Quarter)	3.62M	3.04M	4.74M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M	2.25M
EBIT (Quarter)	3.62M	3.04M	4.74M	7.33M	3.59M	5.08M	6.60M	5.12M	5.13M	5.75M	6.27M	4.47M	3.46M	2.13M	1.02M	1.41M	1.24M	1.37M	23.45M	2.25M
Non-operating items
Non Operating Investment Income (Quarter)											-3.50M
Interest & Investment Income (Quarter)	-0.20M	-0.26M	-0.32M	-0.06M	-0.14M	-0.39M	-0.84M	-0.28M	-0.40M	-1.11M	-0.99M	-0.10M	-0.28M	-0.41M	-0.87M	-0.05M	-0.11M	-0.23M	-0.42M	-0.02M
Other Non Operating Income (Quarter)											-3.50M		-0.95M	-1.85M	-0.08M				0.06M
Non Operating Income (Quarter)	0.02M	-0.05M	0.01M	-0.01M	-0.04M	-0.23M	-0.56M	-0.22M		-0.69M	-1.41M	-0.69M		-1.47M	-0.60M	-0.95M		-0.06M	0.20M	-2.16M
Net income details
EBT (Quarter)	3.32M	3.64M	4.35M	7.23M	4.30M	4.67M	5.74M	4.79M	4.59M	4.62M	3.19M	4.35M	3.15M	1.21M	0.22M	1.32M	1.15M	1.13M	22.81M	2.20M
Profit After Tax (Quarter)	3.64M	3.15M	-4.75M	-7.32M	3.55M	4.85M	-6.04M	-4.90M	5.16M	5.05M	4.86M	3.78M	2.42M	0.67M	0.41M	0.46M	1.09M	1.30M	23.64M	-0.09M
Income from Non-Controlling Interests (Quarter)	0.33M	0.31M	0.03M	0.02M	0.02M	0.03M	0.03M	0.16M	0.02M	0.02M	0.03M	0.07M	0.06M	0.01M	0.01M	0.05M	0.00M	0.00M	0.10M	0.00M
Income from Continuing Operations (Quarter)	3.32M	3.64M	4.35M	7.23M	4.30M	4.67M	5.74M	4.79M	4.59M	4.62M	3.19M	4.35M	3.15M	1.21M	0.22M	1.32M	1.15M	1.13M	22.81M	2.20M
Consolidated Net Income (Quarter)	-0.00M	0.15M	0.35M	7.23M	4.30M	4.67M	5.74M	4.79M	4.59M	4.62M	3.19M	4.35M	3.15M	1.21M	0.22M	1.32M	1.15M	1.13M	22.81M	2.20M
Income towards Parent Company (Quarter)	3.63M	3.14M	5.07M	7.30M	3.56M	4.82M	6.01M	4.88M	5.14M	5.04M	4.83M	3.78M	2.41M	0.66M	0.41M	0.45M	1.08M	1.30M	23.55M	0.09M
Net Income towards Common Stockholders (Quarter)	3.64M	3.15M	5.07M	7.30M	3.56M	4.82M	6.01M	4.88M	5.14M	5.04M	4.83M	3.78M	2.41M	0.66M	0.41M	0.45M	1.08M	1.30M	23.55M	0.09M
Additional items
EPS (Basic) (Quarter)	0.03	0.03	0.29	0.06	0.03	0.04	6.65	0.04	0.04	0.04	0.04	0.03	0.02	0.00	0.00	0.00	0.01	0.01	0.15	0.00
EPS (Weighted Average and Diluted) (Quarter)							6.65				4.36				0.25				49.05
Shares Outstanding (Weighted Average) (Quarter)	122.21M	122.21M	17.57M	124.36M	124.95M	125.75M	0.90M	130.72M	132.25M	133.02M	133.18M	133.70M	135.60M	143.65M	147.63M	147.94M	149.82M	151.83M	152.48M	153.71M
Shares Outstanding (Diluted Average) (Quarter)							0.90M				1.11M				1.64M				0.48M
EBITDA (Quarter)	3.64M	3.15M	5.11M	7.38M	3.57M	4.84M	6.03M	4.90M	5.16M	5.05M	4.84M	3.80M	2.42M	0.67M	0.41M	0.46M	1.09M	1.30M	23.64M	0.09M
Interest Expenses (Quarter)	0.10M	-0.86M	0.07M	0.04M	-0.86M	0.02M	0.02M	0.06M	0.15M	0.02M	2.09M	0.02M	0.02M	0.51M	-0.07M	0.04M	-0.02M	0.01M	0.21M	0.03M

Research Tools

Developers

Purple Biotech Income Statement (2014-2026) | PPBT

Research Tools

Developers

Purple Biotech Income Statement (2014-2026) | PPBT

Create an account

Sign In

Reset Password